NVS-PAK1-1是一种强效的别构抑制剂,抑制p21激活激酶PAK1,PAK1是一种在许多癌症中上调的丝氨酸/苏氨酸激酶。在体外去磷酸化实验中,NVS-PAK1-1对去磷酸化PAK1的IC50值为5 nM,对磷酸化PAK1的IC50值为6 nM。
规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} | 现货 | 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
产品名称 | PAK ↓ ↑ | PAK1 ↓ ↑ | PAK2 ↓ ↑ | PAK3 ↓ ↑ | PAK4 ↓ ↑ | PAK5 ↓ ↑ | PAK6 ↓ ↑ | 其他靶点 | 纯度 | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
IPA-3 |
+
PAK1, IC50: 2.5 μM |
+
PAK1, IC50: 2.5 μM |
99%+ | ||||||||||||||||
FRAX486 |
+++
PAK4, IC50: 39 nM PAK1, IC50: 14 nM |
+++
PAK1, IC50: 14 nM |
++
PAK2, IC50: 33 nM |
++
PAK3, IC50: 39 nM |
+
PAK4, IC50: 575 nM |
99%+ | |||||||||||||
FRAX1036 |
++
PAK2, Ki: 72.4 nM PAK4, Ki: 23.3 nM |
++
PAK1, Ki: 23.3 nM |
++
PAK2, Ki: 72.4 nM |
+
PAK4, Ki: 2.4 μM |
99%+ | ||||||||||||||
FRAX597 |
++++
PAK2, IC50: 13 nM PAK3, IC50: 13 nM |
++++
PAK1, IC50: 8 nM |
++++
PAK2, IC50: 13 nM |
+++
PAK3, IC50: 19 nM |
98+% | ||||||||||||||
PF-3758309 |
++++
PAK3, IC50: 190 nM PAK6, Ki: 17.1 nM |
++++
PAK1, Ki: 13.7 nM |
+
PAK2, IC50: 190 nM |
++
PAK3, IC50: 99 nM |
+++
PAK4, Ki: 18.7 nM |
+++
PAK5, Ki: 18.1 nM |
+++
PAK6, Ki: 17.1 nM |
99%+ | |||||||||||
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 |
描述 | PAK1 is a serine/threonine protein kinase involved in cytoskeletal signaling and oncogenic transformation. The dysregulation of PAK1 has been reported in breast, squamous NSCLC, and pancreatic cancers. NVS-PAK1-1 is a potent, selective, allosteric PAK1 Inhibitor with an IC50 value of 5nM. It has a biochemical PAK1 Kd of 7nM and a PAK2 Kd of 400nM. NVS-PAK1-1 significantly inhibited pMEK Ser289 at a concentration of 6–20μM. It inhibited the proliferation of Su86.86 cells at a concentration of 2μM. NVS-PAK1-1 at 0.21μM also significantly inhibited downstream signaling and cell proliferation when applied together with PAK2 shRNA. NVS-PAK1-1 exhibited high Caco2 permeability (Papp A-B 42.8 × 10-8cm/s). NVS-PAK1-1 showed a relatively poor stability in rat liver microsomes (t1/2=3.5min)[2]. |
计算器 | ||||
存储液制备 | 1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
2.08mL 0.42mL 0.21mL |
10.42mL 2.08mL 1.04mL |
20.84mL 4.17mL 2.08mL |
CAS号 | 1783816-74-9 |
分子式 | C23H25ClF3N5O |
分子量 | 479.926 |
别名 | |
运输 | 蓝冰 |
存储条件 |
In solvent -20°C:3-6个月-80°C:12个月 Pure form Keep in dark place,Inert atmosphere,2-8°C |
溶解方案 |
DMSO: 105 mg/mL(218.78 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
动物实验配方 |